GB0213267D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB0213267D0
GB0213267D0 GB0213267A GB0213267A GB0213267D0 GB 0213267 D0 GB0213267 D0 GB 0213267D0 GB 0213267 A GB0213267 A GB 0213267A GB 0213267 A GB0213267 A GB 0213267A GB 0213267 D0 GB0213267 D0 GB 0213267D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0213267A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0213267A priority Critical patent/GB0213267D0/en
Publication of GB0213267D0 publication Critical patent/GB0213267D0/en
Priority to ES03706732T priority patent/ES2286406T3/en
Priority to DE60313956T priority patent/DE60313956T2/en
Priority to AU2003208444A priority patent/AU2003208444B2/en
Priority to DK03706732T priority patent/DK1480679T3/en
Priority to IL16364203A priority patent/IL163642A0/en
Priority to KR1020107016079A priority patent/KR20100090726A/en
Priority to EP03706732A priority patent/EP1480679B1/en
Priority to AT03706732T priority patent/ATE362771T1/en
Priority to BRPI0307786A priority patent/BRPI0307786B8/en
Priority to CA2476587A priority patent/CA2476587C/en
Priority to PT03706732T priority patent/PT1480679E/en
Priority to US10/505,231 priority patent/US20050163835A1/en
Priority to PL372215A priority patent/PL208114B1/en
Priority to PCT/GB2003/000803 priority patent/WO2003072139A1/en
Priority to SI200330875T priority patent/SI1480679T1/en
Priority to KR1020047013177A priority patent/KR101002374B1/en
Priority to MXPA04008307A priority patent/MXPA04008307A/en
Priority to MYPI20030631A priority patent/MY135609A/en
Priority to CNB038046164A priority patent/CN1326569C/en
Priority to UA20040907788A priority patent/UA76325C2/en
Priority to JP2003570883A priority patent/JP4544863B2/en
Priority to RU2004129280/15A priority patent/RU2318518C2/en
Priority to NZ534513A priority patent/NZ534513A/en
Priority to TW092103905A priority patent/TWI271193B/en
Priority to ARP030100636A priority patent/AR038848A1/en
Priority to UY27682A priority patent/UY27682A1/en
Priority to SA03240043A priority patent/SA03240043B1/en
Priority to IL163642A priority patent/IL163642A/en
Priority to CO04082661A priority patent/CO5601038A2/en
Priority to IS7420A priority patent/IS2462B/en
Priority to NO20043866A priority patent/NO328658B1/en
Priority to HK05103383A priority patent/HK1070585A1/en
Priority to CY20071100974T priority patent/CY1108026T1/en
Priority to US12/234,321 priority patent/US20090186890A1/en
Ceased legal-status Critical Current

Links

GB0213267A 2002-02-26 2002-06-11 Pharmaceutical composition Ceased GB0213267D0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
GB0213267A GB0213267D0 (en) 2002-06-11 2002-06-11 Pharmaceutical composition
MXPA04008307A MXPA04008307A (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative.
KR1020047013177A KR101002374B1 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
MYPI20030631A MY135609A (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
AU2003208444A AU2003208444B2 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
DE60313956T DE60313956T2 (en) 2002-02-26 2003-02-24 PHARMACEUTICAL IRESSA COMPOSITION CONTAINING A WATER SOLUBLE CELLULOSE DERIVATIVE
IL16364203A IL163642A0 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
CNB038046164A CN1326569C (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative
EP03706732A EP1480679B1 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
AT03706732T ATE362771T1 (en) 2002-02-26 2003-02-24 PHARMACEUTICAL IRESSA COMPOSITION CONTAINING A WATER-SOLUBLE CELLULOSE DERIVATIVE
BRPI0307786A BRPI0307786B8 (en) 2002-02-26 2003-02-24 pharmaceutical composition, method of preparing the same, methods of inhibiting the rate of precipitation of the agent from solution in the gi tract, and to reduce inter-patient variability with respect to bioavailability and/or plasma concentrations of the agent, and, use of a water-soluble cellulose ether or an ester of a water-soluble cellulose ether
CA2476587A CA2476587C (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
PT03706732T PT1480679E (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
US10/505,231 US20050163835A1 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
PL372215A PL208114B1 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
PCT/GB2003/000803 WO2003072139A1 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
SI200330875T SI1480679T1 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
ES03706732T ES2286406T3 (en) 2002-02-26 2003-02-24 PHARMACEUTICAL FORMULATION OF IRESSA THAT INCLUDES A WATER SOLUBLE CELLULOSE DERIVATIVE.
NZ534513A NZ534513A (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
DK03706732T DK1480679T3 (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
KR1020107016079A KR20100090726A (en) 2002-02-26 2003-02-24 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
UA20040907788A UA76325C2 (en) 2002-02-26 2003-02-24 Iressy, drug containing water-soluble cellulose derivative (variants) and method for its manufacture
JP2003570883A JP4544863B2 (en) 2002-02-26 2003-02-24 Iressa pharmaceutical formulation containing water-soluble cellulose derivative
RU2004129280/15A RU2318518C2 (en) 2002-02-26 2003-02-24 Pharmaceutical composition possessing anti-proliferative effect (variants), method for its preparing and methods for its using
TW092103905A TWI271193B (en) 2002-02-26 2003-02-25 Pharmaceutical composition comprising 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline or a pharmaceutically-acceptable salt thereof
ARP030100636A AR038848A1 (en) 2002-02-26 2003-02-26 PHARMACEUTICAL COMPOSITION
UY27682A UY27682A1 (en) 2002-02-26 2003-02-26 PHARMACEUTICAL COMPOSITIONS
SA03240043A SA03240043B1 (en) 2002-02-26 2003-03-16 pharmaceutical composition
IL163642A IL163642A (en) 2002-02-26 2004-08-19 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
CO04082661A CO5601038A2 (en) 2002-02-26 2004-08-24 IRESSA PHARMACEUTICAL FORMULATION THAT INCLUDES A HYDROSOLUBLE CELLULOSE DERIVATIVE
IS7420A IS2462B (en) 2002-02-26 2004-08-24 Irresistant formulation containing water-soluble cellulose derivative
NO20043866A NO328658B1 (en) 2002-02-26 2004-09-15 Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative, preparation thereof, and use thereof
HK05103383A HK1070585A1 (en) 2002-02-26 2005-04-20 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
CY20071100974T CY1108026T1 (en) 2002-02-26 2007-07-20 IRESSA PHARMACEUTICAL STANDARDIZATION INCLUDING A WATER SOLUTION CELLULAR PRODUCER
US12/234,321 US20090186890A1 (en) 2002-02-26 2008-09-19 Pharmaceutical Formulation of Iressa Comprising a Water-Soluble Cellulose Derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0213267A GB0213267D0 (en) 2002-06-11 2002-06-11 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB0213267D0 true GB0213267D0 (en) 2002-07-24

Family

ID=9938274

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0213267A Ceased GB0213267D0 (en) 2002-02-26 2002-06-11 Pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB0213267D0 (en)

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
AU2003291103A8 (en) Pharmaceutical composition
IL164547A0 (en) Pharmaceutical composition
GB2391473B (en) Pharmaceutical compositions
AU2003250372A8 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0213481D0 (en) Pharmaceutical compositions
GB0300885D0 (en) Pharmaceutical composition
HK1081451A1 (en) Medicinal composition
HK1065477A1 (en) Pharmaceutical composition
GB0306933D0 (en) Pharmaceutical composition
HK1062274A1 (en) Medicinal composition
GB0307869D0 (en) Pharmaceutical composition
PL370907A1 (en) Pharmaceutical compositions
GB0307862D0 (en) Pharmaceutical composition
GB0307864D0 (en) Pharmaceutical composition
GB0307867D0 (en) Pharmaceutical composition
GB0217703D0 (en) Pharmaceutical composition
EP1547593A4 (en) Medicinal composition
GB0201891D0 (en) Pharmaceutical composition
GB0210238D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)